Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta

Go back to Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
Abbott Laboratories (NYSE: ABT) Delayed: 100.68 +1.85 (1.87%)
Previous Close $98.83    52 Week High $46.38 
Open $101.00    52 Week Low $36.00 
Day High $102.13    P/E 67.12 
Day Low $99.47    EPS $1.50 
Volume 19,913,749       

Amgen Inc (NASDAQ: AMGN) Delayed: 366.29 -5.29 (1.42%)
Previous Close $371.58    52 Week High $176.85 
Open $373.97    52 Week Low $133.64 
Day High $378.54    P/E 55.16 
Day Low $361.72    EPS $6.64 
Volume 2,861,316       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 51.76 -1.01 (1.91%)
Previous Close $52.77    52 Week High $45.58 
Open $51.07    52 Week Low $37.82 
Day High $52.27    P/E N/A 
Day Low $51.04    EPS $0.00 
Volume 10,759,761       

Human Genome Sciences, Inc. (NASDAQ: HGSI) Delayed: 14.24 --0 (-0%)
Previous Close $14.24    52 Week High $16.58 
Open $55.80    52 Week Low $6.51 
Day High $14.24    P/E N/A 
Day Low $14.24    EPS $-1.79 
Volume 557,147       

Johnson & Johnson (NYSE: JNJ) Delayed: 253.04 +3.07 (1.23%)
Previous Close $249.97    52 Week High $126.07 
Open $252.59    52 Week Low $94.28 
Day High $255.66    P/E 52.61 
Day Low $251.95    EPS $4.81 
Volume 10,167,356       

Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 51.60 +0.15 (0.29%)
Previous Close $51.45    52 Week High $35.13 
Open $51.59    52 Week Low $28.10 
Day High $51.87    P/E N/A 
Day Low $51.34    EPS $0.00 
Volume 1,653,533